Brief: Organovo Receives Orphan Designation From U.S. FDA For 3D Bioprinted Therapeutic Liver Tissue

VivoSim Labs

26/12/2017 13:05

Dec 26 (Reuters) - Organovo Holdings Inc  ONVO.O : 
    * ORGANOVO RECEIVES ORPHAN DESIGNATION FROM U.S. FDA FOR 3D 
BIOPRINTED THERAPEUTIC LIVER TISSUE TREATMENT OF ALPHA-1 
ANTITRYPSIN DEFICIENCY 
 
Source text for Eikon:  ID:nGNXOKEZAa  
Further company coverage:  ONVO.O  
 
 (((Bangalore.newsroom@thomsonreuters.com);))